For a rational antibiotics' utilization in hospital;Pour une utilisation rationnelle des antibiotiques en milieu hospitalier

Revue Medicale de Bruxelles

Volumn 22, Issue 1, 2001, Pages 15-25

  Legrand, J C ^a   Struelens, M ^b  

^a Centre Hospitalier Universitaire de Charleroi   (Belgium)

^b NONE

Author keywords

Antibiotic policy; Antibiotic resistance; Antibiotics use; Nosocomial infections; Quality of care

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; ANTIBIOTIC AGENT; BETA LACTAMASE; CEPHALOSPORIN; ERYTHROMYCIN; GLYCOPEPTIDE; METICILLIN; VANCOMYCIN;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL INFECTION; DRUG EFFICACY; DRUG UTILIZATION; HEALTH CARE POLICY; HOSPITAL INFECTION; HUMAN; MEDICAL EDUCATION; MEDICAL PRACTICE; PRACTICE GUIDELINE; PRESCRIPTION;

CROSS INFECTION; DRUG RESISTANCE, MICROBIAL; DRUG UTILIZATION; GUIDELINE ADHERENCE; HOSPITALS; HUMANS; ORGANIZATIONAL POLICY; PATIENT SELECTION; PHYSICIAN'S PRACTICE PATTERNS; PRACTICE GUIDELINES;

EID: 0035116016     PISSN: 00353639     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (81)

1. Gross PA : Fractice guidelines for infectious diseases : rationale for a work in progress. Clin Infect Dis 1998 ; 26 : 1037-41
2. Levy SB : Biological warfare : Homo sapiens versus bacteria. Infect Dis Clin Pract 1998 ; 7 (suppl 3) : S160-7
3. Waldvogel FA : New resistance in Staphyloccoccus aureus. N Engl J Med 1999 ; 340 : 556-7
4. th edition. 2000 : 857-902
5. Shlaes DM et al : Antimicrobial resistance : new directions. ASM News 1991 ; 57 : 455-63
6. Cunha BA : Antibiotic resistance, control strategies. Crit Care Clin 1998 ; 14 : 309-27
7. Shlaes DM et al : Society for Healthcare Epidemiology of America and Infectious Diseases Society of America joint committee on the prevention of antimicrobial resistance : guidelines for the prevention of antimicrobial resistance in hospitals. Infect Control Hosp Epidemiol 1997 ; 18 : 275-91
8. Gdepih-Gospiz : Belgian consensus strategies to control antibiotic-resistant bacteria in hospitals. Acta Clin Belg 1999 ; 54 : 15-6
9. ANDEM : Recommandations pour la pratique clinique le bon usage des antibiotiques à l'hôpital, recommandations pour maîtriser le développement de la résistance bactérienne. La Lettre de l'infectiologue 1997 ; 12 : 77-82
10. Mc Gowan JE Jr : Antibiotic resistance in hospital bacteria : current patterns, modes of appearance or spread, and economic impact. Rev Med Microbiol 1991 ; 2 : 161-9
11. Levy S : Balancing the drug-resistance equation. Trends Microbiol 1994 ; 2 : 341-2
12. Campillo B, Dupeyron C et al : Epidemiology of severe hospital-acquired infections in patients with liver cirrhosis : effect of long-term administration of norfloxacin. Clin Infect Dis 1998 ; 26 : 1066-70
13. Guillemot D, Carbon C, Balkau B et al : Low dosage and long treatment duration of beta-lactam : risk factor for carriage of penicillin-resistant Streptococcus pneumoniae. JAMA 1998 ; 279 : 365-70
14. Seppala H, Klaukka T, Vuopio-Varkila J et al and the Finnish Study Group for Antimicrobial Resistance : The effect of changes in the consumption of macrolide antibiotics on erythromycine resistance of group A streptococci in Finland. N Engl J Med 1997 ; 337 : 441-6
15. Struelens MJ, Byl B, Vincent JL : Antibiotic policy : a tool for controlling resistance of hospital pathogens. Clin Microbiol Infect 1999 ; 5 : S19-24
16. Mc Gowan JE Jr : Do intensive hospital antibiotic control programs prevent the spread of antibiotic resistance ? Infect Control Hosp Epidemiol 1994 ; 15 : 478-83
17. Duncan RA : Controlling use of antimicrobial agents. Infect Control Hosp Epidemiol 1997 ; 18 : 260-6
18. Gyssens IC : How to optimize prescription of antimicrobial drugs. Acta Clin Belg 1999 ; 54 : 7-12
19. Hekster YA, Vree TB, Goris RJA, Boerema JBJ : The defined daily dose per 100 bed days as a unit of comparison and a parameter for studying antimicrobial drug use in an university hospital. J Clin Hosp Pharm 1982 ; 7 : 251-60
20. Cunha BA : Problems arising in antimicrobial therapy due to false susceptibility testing. J Chemother 1997 ; 9 (suppl 1) : 25-35
21. Livermore DM : β-lactamases in laboratory and clinical resistance. Clin Microbiol Rev 1995 ; 8 : 557-84
22. Piroth L, Aubé H, Doise JM, Vincent-Martin M : Spread of extended-spectrum-beta-lactamase-producing Klebsiella pneumoniae : are beta-lactamase inhibitors of therapeutic value ? Clin Infect Dis 1998 ; 27 : 76-80
23. Sanders CC, Iaconis JP, Bodey GP, Samonis G : Resistance to ticarcillin-potassium clavulanate among clinical isolates of the family Enterobacteriacae : role of PSE-ESBL-1 beta-lactamase and high levels of TEM-1 and SHV-1 and problems with false susceptibility in disk diffusion tests. Antimicrob Agents Chemother 1988 ; 32 : 1365-9
24. Bartlett JG, Breiman RF, Mandell LA, File TM Jr : Community-acquired pneumonia in adults : guidelines for management. Clin Infect Dis 1998 ; 26 : 811-38
25. Valke Y, Van Laethem Y, Van Eldere J et al : Diagnostic initial et démarche thérapeutique dans la pneumonie extrahospitalière de l'adulte immunocompétent. Infectious Diseases Advisory Board. Symposium du 14.01.2000. ISBN 2-9600158-3-5
26. Recommendations for preventing the spread of vancomycin resistance : recommendations of the Hospital Infection Control Practices Advisory Committee (HICPAC). Morb Mortal Wkly Rep 1995 ; 44 : 1-13
27. Gordts B, Maertens J, Firre E, Struelens M, Legrand JC, Jordens P : Recommandations pour l'utilisation rationnelle des glycopeptides. Infectious Diseases Advisory Board. Symposium du 14.01.2000. ISBN 2-9600158-2-7
28. Martin C : Recommandation pour la pratique de l'antibioprophylaxie en chirurgie : actualisation 1999. Société Française d'Anesthésie et de Réanimation. La Lettre de l'infectiologue 1999 ; 14 : 205-6
29. Nickman NA et al : Medical committee enforcement of policy limiting post-surgical antibiotic use. Am J Hosp Pharm 1984 ; 41 : 2053-6
30. Peetermans WE : Prophylactic, empiric and therapeutic use of antibiotics. Do we need a guide : an universal edition or a local one ? Eur J Emerg Med 1997 ; 4 : 15-8
31. Gould IM et al : Working Party Report : Hospital antibiotic control measures in the UK. J Antimicrob Chemother 1994 ; 34 : 21-42
32. Moosdeen F, Keeble T, Williams JD : Induction/inhibition of chromosomal β-lactamases by β-lactamases inhibitors. Rev Infect Dis 1986 ; 8 : S562-8
33. Mebis J, Goossens H, Bruyneel P, Sion JP et al : Decreasing antibiotic resistance of Enterobacteriaceae by introducing a new antibiotic combination therapy for neutropenic fever patients. Leukemia 1998 ; 12 : 1627-9
34. Carmeli Y, Troillet N, Eliopoulos GM, Samore MH : Emergence of antibiotic-resistant Pseudomonas aeruginosa : comparison of risks associated with different antipseudomonal agents. Antimicrob Agents Chemother 1999 ; 43 : 1379-82
35. Polk R : Optimal use of modern antibiotics : emerging trends. Clin Infect Dis 1999 ; 29 : 264-74
36. John JF Jr, Fishman NO : Programmatic role of the infectious disease physician in controlling antimicrobial costs in the hospital. Clin Infect Dis 1997 ; 24 : 471-85
37. Joshi N, Milfred D : The use and misuse of new antibiotics. Arch Intern Med 1995 ; 155 : 569-77
38. Metlay JP, Stafford RS, Singer DE : National trends in the use of antibiotics by primary care physicians for adult patients with cough. Arch Intern Med 1998 ; 158 : 1813-8
39. Butler CC, Rollnick S, Pill R, Maggs-Rapport F, Scott N : Understanding the culture of prescribing : qualitative study of general practitioners' and patients' perceptions of antibiotics for sore throats. BMJ 1998 ; 317 : 637-42
40. White AC Jr, Atmar RL, Wilson J et al : Effects of requiring prior authorization for selected antimicrobials : expenditures, susceptibilities and clinical outcomes. Clin Infect Dis 1997 ; 25 : 230-9
41. DeVito et al : Effect of formulary restriction of cefotaxime usage. Arch Intern Med 1985 ; 145 : 1053-6
42. Woodward RS et al : Antibiotic cost savings from formulary restrictions and physician monitoring in a medical school affiliated hospital. Am J Med 1987 ; 83 : 817-23
43. Achusim LE : Antibiotic use following implementation of a therapeutic interchange program. Pharmacol Ther 1992 ; 17 : 775-98
44. Mac Gregor RR, Graziani AL : Oral administration of antibiotics : a rational alternative to the parenteral route. Clin Infect Dis 1997 ; 24 : 457-67
45. Cunha BA : Intensive care, not intensive antibiotics. Heart & Lung 1994 ; 23 : 361-2
46. Strausbaugh L : Antimicrobial resistance : problems, laments and hopes. Am J Infect Control 1997 ; 25 : 294-6
47. Feely J, Chan R et al : Hospital formularies : need for continuous intervention. BMJ 1990 ; 300 : 28-30
48. King JW et al : Alterations in the micro-flora and the incidence of bacteremia at a university hospital after adoption of amikacin as the sole formulary aminoglucoside. Clin Infect Dis 1992 ; 14 : 908-15
49. rd generation cephalosporin use in a teaching hospital. Arch Intern Med 1992 ; 152 : 554-7
50. Friedland IR et al : Increased resistance to amikacin in a neonatal unit following intensive amikacin usage. Antimicrob Agents Chemother 1992 ; 36 : 1596-600
51. Mc Gowan JE Jr : Minimizing antimicrobial resistance in hospital bacteria : can switching or cycling drugs help ? Infect Control Hosp Epidemiol 1987 ; 7 : 573-6
52. Schentag JJ, Hyatt JM et al : Genesis of methicillin-resistant Staphylococcus aureus, how treatment of MRSA infections has selected for vancomycin-resistant Enterococcus faecium and the importance of antibiotic management and infection control. Clin Infect Dis 1998 ; 26 : 1204-14
53. McGowan JE Jr : Drug resistance and nosocomial infections : epidemiology and prevention strategies. Clin Infect Dis 1999 ; 5 : 177-92
54. Thomas JK, Forrest A, Bhavnani SM et al : Pharmacodynamic evaluation of factors associated with the development of bacterial resistance in acutely ill patients during therapy. Antimicrob Agents Chemother 1998 ; 42 : 521-7
55. Forest A, Nix DE, Ballow CH et al : Pharmacodynamics of intravenous ciprofloxacin in seriously ill patients. Antimicr Agents Chemoth 1991 ; 37 : 1073-81
56. Ives TJ et al : Effect of an educational intervention on oral cephalosporin use in primary care. Arch Intern Med 1987 ; 147 : 44-7
57. Gould IM, Jappy B : Trends in hospital antibiotic prescribing after introduction of an antibiotic policy. J Antimicrob Chemoth 1996 ; 38 : 895-904
58. Byl B, Clevenbergh P, Jacobs F, Struelens MJ et al : Impact of infectious diseases specialists and microbiological data on the appropriateness of antimicrobial therapy for bacteremia. Clin Infect Dis 1999 ; 29 : 60-6
59. Durbin A Jr et al : Improved antibiotic usage following introduction of a novel prescription system. JAMA 1981 ; 246 : 1796-800
60. Echols RM et al : The use of an antibiotic order form for antibiotic utilization review : influence on physicians' prescribing patterns. J Infect Dis 1984 ; 6 : 803-7
61. Coleman RW, Rodondi LC et al : Cost-effectiveness of prospective and continuous antibiotic control : experience at the Palo Alto Veterans Affairs Medical Center from 1987 to 1989. Am J Med 1991 ; 90 : 439-44
62. Evans RS, Pestotnik SL, Classen DC, Clemmer TP et al : A computer-assisted management program for antibiotics and other anti-infective agents. N Engl J Med 1998 ; 338 : 232-8
63. Soumerai SB et al : Computer-based drug utilization review : risk, benefit or boondoggle ? N Engl J Med 1995 ; 332 : 1641-5
64. Pestotnik SL, Classen DC, Evans RS et al : Implementing antibiotic practice guidelines through computer-assisted decision support : clinical and financial outcomes. Ann Intern Med 1996 ; 124 : 884-90
65. Fowler VG Jr, Sanders LL, Sexton DJ et al : Outcome of Staphylococcus aureus bacteremia according to compliance with recommendations of infectious diseases specialists : experience with 244 patients. Clin Infect Dis 1998 ; 27 : 478-86
66. Magnussen CR : Infectious diseases curbside consultations at a community hospital. Infect Dis Clin Pract 1992 ; 1 : 391-4
67. Manian FA, Mc Kinsey DS : A prospective study of 2.092 " curbside " questions asked of two infectious disease consultants in private practice in the Midwest. Clin Infect Dis 1996 ; 22 : 303-7
68. Tice AD, Poretz DM : Lessons in managed care. Infect Dis Clin Pract 1997 ; 6 : 374-7
69. Fox BC, Siegel ML, Weinstein RA : " Curbside " consultation and informal communication in medical practice : a medico-legal perspective. Clin Infect Dis 1996 ; 23 : 616-22
70. Classen DC, Burke JP, Wenzel RP : Infectious diseases consultation : impact on outcomes for hospitalized patients and results of a preliminary study. Clin Infect Dis 1997 ; 24 : 464-70
71. Nathwani D et al : Impact of an infection consultation service for bacteremia on clinical management and use of ressources. Q J Med 1996 ; 789-97
72. Evans RS et al : Computer surveillance of hospital acquired infections and antibiotic use. JAMA 1986 ; 256 : 1007-11
73. Schentag JJ et al : Changes in antimicrobial agent usage resulting from interactions among clinical pharmacy, the infectious disease division and the microbiology laboratory. Diagn Microbiol Infect Dis 1993 ; 16 : 255-64
74. Gyssens JC, Van den broeck PJ, Kulberg BJ, Hekster YA, Van der Meer JWM : Optimizing antimicrobial therapy. A method for antimicrobial drug use evaluation. J Antimicrob Chemother 1992 ; 30 : 724-7
75. Goldmann DA et al : Strategies to prevent and control the emergence and spread of antibiotic-resistant microorganisms in hospitals. A challenge to hospital leadership. Workshop to prevent and control the emergence and spread of antibiotic-resistant microorganism in hospital. JAMA 1996 ; 275 : 234-40
76. Struelens MJ, Peetermans WE : The antimicrobial resistance crisis in hospitals calls for multidisciplinary mobilization. Acta Clin Belg 1999 ; 54 : 2-6
77. Stren Z et al : The role of a hospital director in efforts to reduce infections after surgical procedures : a report of intervention in cardiac surgery. Clin Performance Quality Health Care 1994 ; 2 : 135-40
78. nd edition. Baltimore, Williams and Wilkins, 1993 : 406-19
79. Nagler J, Peetermans W, Goossens H, Struelens M : National committee for the coordination of antibiotic policy in Belgium : the next step in the fight against antimicrobial resistance. Acta Clinica Belg 1999 ; 54 : 319-20
80. Bauraind I : Un nouvel outil de santé publique : la Commission de coordination de la politique antibiotique. Noso-Info 2000 ; 4 : 9-12
81. Guillemot D Antibiotic use in humans and bacterial resistance. Curr Opin Microbiol 1999 ; 2 : 494-8